about
The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?A delicate balance between rejection and BK polyomavirus associated nephropathy; A retrospective cohort study in renal transplant recipientsImpact of Muscarinic M3 Receptor Antagonism on the Risk of Type 2 Diabetes in Antidepressant-Treated Patients: A Case-Controlled Study.Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies.The influence of underweight and obesity on the diagnosis and treatment of appendicitis in childrenStillbirth and neonatal mortality in pregnancies complicated by major congenital anomalies: findings from a large European cohort.Angiotensin II responsiveness after preeclampsia: translational data from an experimental rat model and early-onset human preeclampsia.Cost-effectiveness analysis of lifestyle intervention in obese infertile women.Incidence and outcome of BK polyomavirus infection in a multicenter randomized controlled trial with renal transplant patients receiving cyclosporine-, mycophenolate sodium-, or everolimus-based low-dose immunosuppressive therapy.Unconjugated free bilirubin in preterm infants.Blood pressure patterns in women with gestational hypertension or mild preeclampsia at term.Intestinal rehabilitation for children with intestinal failure is cost-effective: a simulation study.Prediction of progression to severe disease in women with late preterm hypertensive disorders of pregnancy.Caesarean section rates and adverse neonatal outcomes after induction of labour versus expectant management in women with an unripe cervix: a secondary analysis of the HYPITAT and DIGITAT trials.In-utero cigarette smoke exposure and the risk of earlier menopause.Prenatal exposure to serotonin reuptake inhibitors and congenital heart anomalies: an exploratory pharmacogenetics study.The prevalence of feeding problems in children formerly treated in a neonatal intensive care unit.Exposure to reactive intermediate-inducing drugs during pregnancy and the incident use of psychotropic medications among children.Randomized Trial of a Lifestyle Program in Obese Infertile Women.Uteroplacental Doppler flow and pregnancy outcome in women with tetralogy of Fallot.An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II).Congenital anomalies in offspring of subfertile couples: a registry-based study in the northern Netherlands.Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.Chromosomal abnormalities in 1663 infertile men with azoospermia: the clinical consequences.Women, their Offspring and iMproving lifestyle for Better cardiovascular health of both (WOMB project): a protocol of the follow-up of a multicentre randomised controlled trial.Effect of a lifestyle intervention in obese infertile women on cardiometabolic health and quality of life: A randomized controlled trial.Kidney Function After a Hypertensive Disorder of Pregnancy: A Longitudinal Study.Low oocyte yield during IVF treatment and the risk of a trisomic pregnancy.Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responder.The efficacy of home telemonitoring versus conventional follow-up: a randomised controlled trial among teenagers with inflammatory bowel disease.Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responder.Atmospheric pressure variation is a delayed trigger for aneurysmal subarachnoid hemorrhage.A lifestyle intervention improves sexual function of women with obesity and infertility: A 5 year follow-up of a RCTRecurrence risk of preeclampsia in a linked population-based cohort: Effects of first pregnancy maximum diastolic blood pressure and gestational ageEffectiveness of lifestyle intervention in subgroups of obese infertile women: a subgroup analysis of a RCTAuthors' reply re: Caesarean section rates and adverse neonatal outcomes after induction of labour versus expectant management in women with an unripe cervix: a secondary analysis of the HYPITAT and DIGITAT trialsThe effects of a pre-conception lifestyle intervention in women with obesity and infertility on perceived stress, mood symptoms, sleep and quality of lifePrediction model of postnatal renal function in fetuses with lower urinary tract obstruction (LUTO)-Development and internal validation
P50
Q26741187-C5B16926-2900-48EF-9C21-B07394A935C5Q33793057-FFFC5C32-F181-43F9-A215-F937A34F87EAQ33845592-B25FE8DE-0028-406D-AD43-489FDBF259A2Q36306228-7760ECDB-02A6-45D1-8677-DE7500ACCD34Q37100142-C6037D2E-E002-4C85-941A-707BF0D979F4Q38610290-ECBE3636-60E9-479C-AD1E-BFD80689150DQ38678915-299671D5-B012-4CB7-B4C3-89B3B1B69D13Q38685942-262A3547-7846-4928-948C-13FE49A7EB5EQ38930188-60665CD8-58FE-4954-85F9-D14483B89E2DQ38969349-5522C900-8BFC-4009-B942-E6A417F7CB11Q38994003-9C32F5D3-D444-4C59-BE04-C7C86AB41943Q39040239-4152B67E-09BE-419A-AB09-947F7B5B33BBQ39238730-B6D8207F-0169-4E8C-B437-7EC8256970ECQ39771239-5C951E3F-E8E0-4064-BD0D-7EEEB11FB219Q40063340-D63AA3A2-867B-426F-AB4E-5FFCB042AD88Q40149970-EEEA059D-04E6-4CA8-9F32-0E98A4C8DD08Q40373578-5AE04EA8-50A8-4399-BCD5-4EA1F8AA6E37Q40376136-DF40C0EB-4620-4A08-8076-8E9C624421DBQ40748153-D96F9F01-E376-4E5A-9FF3-629F2A091D53Q40803997-DEFE8278-7948-45A8-9305-951D6FA7AC5BQ40858287-6F7F1938-6FCD-46DD-998A-81C46EC3D538Q41522367-2A84C890-E8D5-4994-BED3-989332142DC6Q47221797-4C9E1218-4FBB-400F-B948-9BA29A1C3B0DQ47241214-3F043EAE-050C-4474-A58F-C67D984D4A6BQ47551797-73B22D02-DB3B-405E-A411-79991227936DQ47556862-4C8627AB-EFAF-4344-90E8-E95200E10782Q47570025-39F68A2E-54AC-4C46-AA42-CF920A53B272Q47629889-5E30EA6D-546D-4241-A71F-F7964EC7F8A7Q47848951-C53B6E71-D7C2-4ADB-ABCC-5DD2F286100BQ48573532-B12F5D0F-5EF1-4A2C-8FE1-5E1A8E658473Q48605923-27C23D69-BCAC-4572-AA64-104A795A7BB8Q50154223-96B0E0E9-A61F-49E6-B72F-9B899FACCDA1Q57799412-A294902D-1A0B-4508-AADF-CD796D3A1160Q61846425-4E9FDA91-CC68-49A9-BA9D-2A2230CFAD32Q61846434-67016E25-A7B5-4CBF-8C5A-C9AB77F2363FQ61846441-5DD4F2F3-0B80-4042-B043-E9573B13F46EQ64106690-4AA3AA58-7CDD-475F-949A-76D77B7849F2Q90978135-987AEE57-0063-4D75-9601-A0BB6F9337AE
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
H Groen
@ast
H Groen
@en
H Groen
@es
H Groen
@nl
H Groen
@sl
type
label
H Groen
@ast
H Groen
@en
H Groen
@es
H Groen
@nl
H Groen
@sl
prefLabel
H Groen
@ast
H Groen
@en
H Groen
@es
H Groen
@nl
H Groen
@sl
P106
P31
P496
0000-0002-6629-318X